← Leaderboards
Martin John Hessner
Medical College Of Wisconsin
$7,827,766
Attributed
$9,633,290
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,633,290 · 7
By mechanism
R01$7,789,798 · 4
R56$986,750 · 2
DP3$856,742 · 1
Top collaborators
- Susanne M Cabrera5 shared
- Carla J Greenbaum1 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Michael E Widlansky$10,705,548
- Susanne M Cabrera$1,767,039
- Timothy Glenn Heckman$6,812,277
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteInflammatoryImmuneMediatingRattusInsulinInterleukin-1Insulin-Dependent Diabetes MellitusExhibitsGenetic TranscriptionDiabetes MellitusPredispositionRegulatory T-LymphocyteImmunoregulationHigh RiskPathway InteractionsBeta CellCell PhysiologyPeripheral Blood Mononuclear CellInflammationInterleukin-10InsightDisease ProgressionFamily
Grant awards (22)
Reducing innate inflammation in new onset T1D with Lactobacillus plantarum$447,552
R01 · FY2024 · DK · contact PI
Reducing innate inflammation in new onset T1D with Lactobacillus plantarum$613,250
R01 · FY2023 · DK · contact PI
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials$298,171
R01 · FY2023 · DK · contact PI
Reducing innate inflammation in new onset T1D with Lactobacillus plantarum$613,250
R01 · FY2022 · DK · contact PI
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials$527,385
R01 · FY2022 · DK · contact PI
Reducing innate inflammation in new onset T1D with Lactobacillus plantarum$593,943
R01 · FY2021 · DK · contact PI
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials$527,385
R01 · FY2021 · DK · contact PI
Plasma-induced signatures as a measure disease heterogeneity and immunomodulation in T1D clinical trials$523,418
R01 · FY2020 · DK · contact PI
Reducing innate inflammation in new onset T1D with Lactobacillus plantarum$486,312
R01 · FY2020 · DK · contact PI
Plasma Induced Signatures as a Measure of Immunomodulation in T1D Clinical Trials$304,000
R56 · FY2017 · DK · contact PI
Plasma Induced Signatures as a Measure of Immunomodulation in T1D Clinical Trials$304,000
R56 · FY2016 · DK · contact PI
Quantitative measurement of T1D risk through molecular signature analysis$856,742
DP3 · FY2013 · DK · contact PI
Dissection of cellular interactions in T1DM with integrated functional genomics$348,831
R01 · FY2013 · AI · contact PI
Dissection of cellular interactions in T1DM with integrated functional genomics$371,101
R01 · FY2012 · AI · contact PI
Dissection of cellular interactions in T1DM with integrated functional genomics$373,040
R01 · FY2011 · AI · contact PI
Dissection of cellular interactions in T1DM with integrated functional genomics$380,332
R01 · FY2010 · AI · contact PI
Dissection of cellular interactions in T1DM with integrated functional genomics$194,640
R01 · FY2009 · AI · contact PI
Dissection of cellular interactions with integrated functional genomics in comple$378,750
R56 · FY2008 · AI · contact PI
HIGH DENSITY MICROARRAYS WITH QUANTITATIVE QC/QA$366,188
R01 · FY2006 · EB · contact PI
HIGH DENSITY MICROARRAYS WITH QUANTITATIVE QC/QA$375,000
R01 · FY2005 · EB
HIGH DENSITY MICROARRAYS WITH QUANTITATIVE QC/QA$375,000
R01 · FY2004 · EB
HIGH DENSITY MICROARRAYS WITH QUANTITATIVE QC/QA$375,000
R01 · FY2003 · EB